Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Government Shutdown Means New Drugs May Have to Wait – But Safety Monitoring Will Continue

Posted on January 17th, 2019 by

The partial shutdown of the U.S. government, which began just before the Christmas holiday, has been especially terrible for hundreds of thousands of federal employees who are either furloughed or working without pay. Continue reading “Government Shutdown Means New Drugs May Have to Wait – But Safety Monitoring Will Continue” »

Avoiding Pitfalls and Costly Mistakes in Early Stage R&D

Posted on January 17th, 2019 by

Pharma R&D costs continue to rise rapidly. A well-known Tufts study estimated the average pre-tax cost per new approved prescription drug (including failures and capital costs) was nearly $2.6 billion in 2013. However, the creation of novel approved drugs has not kept up with investment over the past two decades. Continue reading “Avoiding Pitfalls and Costly Mistakes in Early Stage R&D” »

FDA Announces Plans to Improve Approvals Process for Medical Devices

Posted on January 15th, 2019 by

In the pharmaceutical industry, safety protocols are rigorous. Clinical trials, a lengthy and intense part of the drug development process, are deemed absolutely crucial to ensuring the safety and efficacy of new drugs and therapies. There are also many regulations designed to make certain that high standards are maintained during the various trial phases.

Continue reading “FDA Announces Plans to Improve Approvals Process for Medical Devices” »

Pharma and Biotech Firms Gather at the 37th Annual J.P. Morgan Healthcare Conference

Posted on January 15th, 2019 by

2019 marks the 37th year of the J.P. Morgan Healthcare Conference, which has come to be one of the premiere annual events for companies involved in all aspects of the industry, from biotech start-ups to large healthcare service providers. Continue reading “Pharma and Biotech Firms Gather at the 37th Annual J.P. Morgan Healthcare Conference” »

  1. 1
  2. 2
  3. 3
  4. 4
  5. 64